Ptc Therapeutics (PTCT) Amortizatization of Intangibles (2014 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Amortizatization of Intangibles of $4.2 million for Q2 2026, down 8.78% year-over-year from $4.6 million in Q2 2025, and up 1.02% quarter-over-quarter from $4.1 million in Q1 2026.
Analysis
Ptc Therapeutics (PTCT) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends
Ptc Therapeutics' Amortizatization of Intangibles history runs 13 years deep, the most recent figure standing at $4.2 million for Q2 2026.
- In Q2 2026, Amortizatization of Intangibles fell 8.78% year-over-year to $4.2 million; the TTM figure through Jun 2026 stood at $19.4 million (up 56.57% YoY), while the FY2025 annual figure was $18.0 million, up 43.84% from the prior year.
- Amortizatization of Intangibles for Q2 2026 stood at $4.2 million, up from $4.1 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $6.1 million in Q3 2025, with the low at -$887000.0 in Q1 2022.
- The 5-year median for Amortizatization of Intangibles is $2.4 million (2024), against an average of $2.2 million.
- The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles jumped 295300.0% in 2024, then sank 37.44% in 2025.
- Ptc Therapeutics' Amortizatization of Intangibles stood at $79000.0 in 2022, then soared by 2572.15% to $2.1 million in 2023, then gained by 22.31% to $2.6 million in 2024, then soared by 95.58% to $5.0 million in 2025, then dropped by 17.7% to $4.2 million in 2026.
- Business Quant data shows PTCT's Amortizatization of Intangibles at $4.2 million in Q2 2026, $4.1 million in Q1 2026, and $5.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Ptc Therapeutics | 5.78 Bn | 3.55 Bn | 340.60 Mn | 4.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.16 Mn |
| Mar 31, 2026 | 4.11 Mn |
| Dec 31, 2025 | 5.05 Mn |
| Sep 30, 2025 | 6.10 Mn |
| Jun 30, 2025 | 4.56 Mn |
| Mar 31, 2025 | 2.31 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Sep 30, 2024 | 2.95 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Mar 31, 2024 | 3.70 Mn |
| Dec 31, 2023 | 1.67 Mn |
| Sep 30, 2023 | 2.48 Mn |
| Jun 30, 2023 | 2.73 Mn |
| Mar 31, 2023 | 2.94 Mn |
| Dec 31, 2022 | 2.38 Mn |
| Sep 30, 2022 | 3.21 Mn |
| Jun 30, 2022 | 2.39 Mn |
| Mar 31, 2022 | 1.91 Mn |
| Dec 31, 2021 | 1.87 Mn |
| Sep 30, 2021 | 1.85 Mn |